Antibody Treatment Makes Inroads Against Multiple Myeloma
MONDAY, Dec. 12, 2022 -- An experimental immunotherapy appears highly effective in attacking bone marrow cancer, with nearly three in four patients responding to the treatment, new clinical trial results show.
The drug, talquetamab, works by...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Clinical Trials | General Medicine | Immunotherapy | Myeloma